Dr. Philipp Kahlert

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Transcatheter aortic valve implantation (TAVI) is a rapidly emerging treatment option for patients with aortic valve stenosis and high surgical risk. Different access routes have been proposed for TAVI including transapical, transsubclavian and transfemoral, with percutaneous transfemoral being the preferred because least invasive and nonsurgical. However,(More)
  • 1